Waldencast plc
No enriched coverage for $WALD in the last 7 days.
No SEC Form 4 filings for $WALD in the last 30 days.
See all $WALD insider activity →U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 500 points on Monday. The Dow traded up 0.65% to 46,546.82 while the NASDAQ rose 2.32% to 22,789.25. The S&P 500 also rose, gaining, 1.40% to 6,696.44. Communication services shares jumped by 3.1% on ...
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday. Shares of Novo Nordisk A/S ( NYSE:NVO ) fell sharply in today's pre-market trading after Evoke Phase 3 trials data showed that GLP-1 drugs did not demonstrate statistically significant ...
Transformation efforts drive performance improvements at Obagi Medical with accelerating revenue ...
Waldencast's shares experienced a significant decline amidst a positive broader market trend, indicating company-specific issues rather than sector-wide concerns.
WALD's neutral sentiment indicates limited immediate impact.
Waldencast's Q2 2025 results indicate improved performance driven by transformation efforts, with a positive outlook for Q3 2025.
Waldencast plc announced a strategic move to strengthen its balance sheet by selling its Obagi trademark in Japan and refinancing credit facilities. This indicates a focus on financial stability and potential capital reallocation.
FDA approval of Obagi® saypha® MagIQ™ enhances Waldencast's product portfolio, potentially boosting revenue and market share in dermatological aesthetics.
alphai scores every news story that mentions WALD with an AI model for sentiment and relevance, and aggregates insider trades from Waldencast plc's SEC EDGAR Form 4 filings. Figures refresh continuously.
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 500 points on Monday. The Dow traded up 0.65% to 46,546.82 while the NASDAQ rose 2.32% to 22,789.25. The S&P 500 also rose, gaining, 1.40% to 6,696.44. Communication services shares jumped by 3.1% on ...
4 min readU.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday. Shares of Novo Nordisk A/S ( NYSE:NVO ) fell sharply in today's pre-market trading after Evoke Phase 3 trials data showed that GLP-1 drugs did not demonstrate statistically significant ...
4 min readTransformation efforts drive performance improvements at Obagi Medical with accelerating revenue ...
4 min readNEW YORK, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Waldencast plc, ( NASDAQ: WALD ) ( "Waldencast" or the "Company" ) , a global multi-brand beauty and wellness platform, today announced that it had sold its rights to the "Obagi" trademark in Japan to Rohto Pharmaceutical Co., Ltd. ( "Rohto" ) for ...
3 min readU.S. Launch Planned in 2026 and Positions Obagi Medical as a Leading Dermatological Megabrand at the Convergence of Integrated Skincare and Aesthetics While Doubling its Addressable Market U.S. Launch Planned in 2026 and Positions Obagi Medical as a Leading Dermatological Megabrand at the ...
4 min readObagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand's Addressable Market in the U.S.
3 min readWaldencast plc WALD will release earnings results for the second quarter after the closing bell on Monday, Aug. 18. Analysts expect the White Plains, New York-based company to report a quarterly loss at 5 cents per share.
2 min readAcquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio ...
3 min readAcquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics convergence
3 min readQ1 Net Revenue of $65.4 million, ( 4.1 ) % decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted ...
2 min read
